2515 related articles for article (PubMed ID: 29195573)
21. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis.
Elmaraezy A; Ismail A; Abushouk AI; Eltoomy M; Saad S; Negida A; Abdelaty OM; Abdallah AR; Aboelfotoh AM; Hassan HM; Elmaraezy AG; Morsi M; Althaher F; Althaher M; AlSafadi AM
BMC Cardiovasc Disord; 2017 Aug; 17(1):234. PubMed ID: 28836953
[TBL] [Abstract][Full Text] [Related]
23. Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.
Elbadawi A; Saad M; Elgendy IY; Barssoum K; Omer MA; Soliman A; Almahmoud MF; Ogunbayo GO; Mentias A; Gilani S; Jneid H; Aronow HD; Kleiman N; Abbott JD
JACC Cardiovasc Interv; 2019 Sep; 12(18):1811-1822. PubMed ID: 31537280
[TBL] [Abstract][Full Text] [Related]
24. TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket Study.
Tchétché D; Chevalier B; Holzhey D; Harnath A; Schäfer U; Teiger E; Manigold T; Modine T; Souteyrand G; Champagnac D; Oh JK; Li S; Verhoye JP; Kornowski R;
JACC Cardiovasc Interv; 2019 May; 12(10):923-932. PubMed ID: 31122349
[TBL] [Abstract][Full Text] [Related]
25. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
26. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
[TBL] [Abstract][Full Text] [Related]
27. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
[TBL] [Abstract][Full Text] [Related]
28. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
[TBL] [Abstract][Full Text] [Related]
29. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
Popma JJ; Reardon MJ; Khabbaz K; Harrison JK; Hughes GC; Kodali S; George I; Deeb GM; Chetcuti S; Kipperman R; Brown J; Qiao H; Slater J; Williams MR
JACC Cardiovasc Interv; 2017 Feb; 10(3):268-275. PubMed ID: 28183466
[TBL] [Abstract][Full Text] [Related]
30. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.
Kleiman NS; Maini BJ; Reardon MJ; Conte J; Katz S; Rajagopal V; Kauten J; Hartman A; McKay R; Hagberg R; Huang J; Popma J;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27601429
[TBL] [Abstract][Full Text] [Related]
31. Causes of death from the randomized CoreValve US Pivotal High-Risk Trial.
Gaudiani V; Deeb GM; Popma JJ; Adams DH; Gleason TG; Conte JV; Zorn GL; Hermiller JB; Chetcuti S; Mumtaz M; Yakubov SJ; Kleiman NS; Huang J; Reardon MJ
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1293-1301.e1. PubMed ID: 28249691
[TBL] [Abstract][Full Text] [Related]
32. Early readmissions after transcatheter and surgical aortic valve replacement.
Vejpongsa P; Bhise V; Charitakis K; Vernon Anderson H; Balan P; Nguyen TC; Estrera AL; Smalling RW; Dhoble A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):662-670. PubMed ID: 28251807
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
[TBL] [Abstract][Full Text] [Related]
34. Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling.
Fuchs A; Kofoed KF; Yoon SH; Schaffner Y; Bieliauskas G; Thyregod HG; Makkar R; Søndergaard L; De Backer O; Bapat V
JACC Cardiovasc Interv; 2018 Sep; 11(17):1733-1743. PubMed ID: 30121280
[TBL] [Abstract][Full Text] [Related]
35. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
[TBL] [Abstract][Full Text] [Related]
36. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
[TBL] [Abstract][Full Text] [Related]
37. Outcome of Patients with Low-Gradient Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement.
Kugelman N; Jaffe R; Aronson D; Sharoni E; Adawi S; Khader N; Shiran A
Cardiovasc Revasc Med; 2020 Mar; 21(3):257-262. PubMed ID: 31103371
[TBL] [Abstract][Full Text] [Related]
38. Comparison of periprocedural and mid-term stroke rates and outcomes between surgical aortic valve replacement and transcatheter aortic valve replacement patients.
Aalaei-Andabili SH; Anderson RD; Petersen JW; Beaver TM; Bavry AA; Klodell CT
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):591-597. PubMed ID: 27078127
[TBL] [Abstract][Full Text] [Related]
39. Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
Salna M; Khalique OK; Chiuzan C; Kurlansky P; Borger MA; Hahn RT; Leon MB; Smith CR; Kodali SK; George I
Catheter Cardiovasc Interv; 2018 Mar; 91(4):765-773. PubMed ID: 28470996
[TBL] [Abstract][Full Text] [Related]
40. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
Dauerman HL; Deeb GM; O'Hair DP; Waksman R; Yakubov SJ; Kleiman NS; Chetcuti SJ; Hermiller JB; Bajwa T; Khabbaz K; de Marchena E; Salerno T; Dries-Devlin JL; Li S; Popma JJ; Reardon MJ
Circ Cardiovasc Interv; 2019 Oct; 12(10):e008155. PubMed ID: 31607151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
